---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-25-000052"
form_type: "8-K/A"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T11:27:11.145628+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics promotes Warren Stone to President & COO; Melody Harris to depart

## Summary
- Warren Stone promoted to President & COO effective April 1, 2025; previously CCO.
- Stone's base salary increased to $650k, target bonus 70%, equity target $3M, plus incremental $1M equity.
- Melody Harris to depart end of May 2025; her role as COO and President, Oncology Data Solutions eliminated.
- Beth Eastland, SVP Enterprise Sales, to support Stone and assume day-to-day enterprise sales functions.

## SEC filing metadata
- accession: 0001077183-25-000052
- form_type: 8-K/A
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/0001077183-25-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/neo-20250318.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-25-000052
- JSON: https://secwatch.observer/filing/0001077183-25-000052.json
- Plain text: https://secwatch.observer/filing/0001077183-25-000052.txt

## Key facts
- Executive change
  Warren Stone changed role as President & Chief Operating Officer at NEOGENOMICS INC.
  - Action: promoted
  - Role: President & Chief Operating Officer
  source text: On March 18, 2025, NeoGenomics, Inc. (the "Company") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/0001077183-25-000052-index.htm
- Executive change
  Melody Harris departed as Chief Operations Officer and President, Oncology Data Solutions at NEOGENOMICS INC.
  - Action: position eliminated
  - Role: Chief Operations Officer and President, Oncology Data Solutions
  source text: Additionally, on March 18, 2025, the Company announced that the Chief Operations Officer and President, Oncology Data Solutions position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer and President, Oncology Data Solutions will no longer hold such role effective April 1, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000052/0001077183-25-000052-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.